Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Cancer Letters
|
May 4, 2007
Pathways to tamoxifen resistance
Rebecca B Riggins, Randy S Schrecengost, Michael S Guerrero, et al.
The Journal of Biological Chemistry
|
November 27, 2009
BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling
Natasha R Schuh, Michael S Guerrero, Randy S Schrecengost, et al.
Cancer Research
|
November 1, 2008
A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells
Huy Q Ta, Keena S Thomas, Randy S Schrecengost, et al.
Plos One
|
June 14, 2013
Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells
Ashley L Wilson, Randy S Schrecengost, Michael S Guerrero, et al.
Cancer Research
|
July 10, 2007
Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling
Randy S Schrecengost, Rebecca B Riggins, Keena S Thomas, et al.
Cancers
|
May 11, 2024
Opaganib Downregulates N-Myc Expression and Suppresses In Vitro and In Vivo Growth of Neuroblastoma Cells
Lynn W Maines, Staci N Keller, Ryan A Smith, et al.
Molecular Cancer Research : MCR
|
August 15, 2015
Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression
Randy S Schrecengost, Staci N Keller, Matthew J Schiewer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 16, 2004
Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-based inhibitors of human N-myristoyltransferase-1
Kevin J French, Yan Zhuang, Randy S Schrecengost, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 14, 2018
In Vitro and In Vivo Antitumor and Anti-Inflammatory Capabilities of the Novel GSK3 and CDK9 Inhibitor ABC1183
Randy S Schrecengost, Cecelia L Green, Yan Zhuang, et al.
Pharmaceutics
|
May 28, 2022
IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma
Julian S Rechberger, Kendra A Porath, Liang Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Cancer Letters
|
May 4, 2007
Pathways to tamoxifen resistance
Rebecca B Riggins, Randy S Schrecengost, Michael S Guerrero, et al.
The Journal of Biological Chemistry
|
November 27, 2009
BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling
Natasha R Schuh, Michael S Guerrero, Randy S Schrecengost, et al.
Cancer Research
|
November 1, 2008
A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells
Huy Q Ta, Keena S Thomas, Randy S Schrecengost, et al.
Plos One
|
June 14, 2013
Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells
Ashley L Wilson, Randy S Schrecengost, Michael S Guerrero, et al.
Cancer Research
|
July 10, 2007
Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling
Randy S Schrecengost, Rebecca B Riggins, Keena S Thomas, et al.
Cancers
|
May 11, 2024
Opaganib Downregulates N-Myc Expression and Suppresses In Vitro and In Vivo Growth of Neuroblastoma Cells
Lynn W Maines, Staci N Keller, Ryan A Smith, et al.
Molecular Cancer Research : MCR
|
August 15, 2015
Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression
Randy S Schrecengost, Staci N Keller, Matthew J Schiewer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 16, 2004
Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-based inhibitors of human N-myristoyltransferase-1
Kevin J French, Yan Zhuang, Randy S Schrecengost, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 14, 2018
In Vitro and In Vivo Antitumor and Anti-Inflammatory Capabilities of the Novel GSK3 and CDK9 Inhibitor ABC1183
Randy S Schrecengost, Cecelia L Green, Yan Zhuang, et al.
Pharmaceutics
|
May 28, 2022
IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma
Julian S Rechberger, Kendra A Porath, Liang Zhang, et al.
Page
of 2